Please login to the form below

Not currently logged in
Email:
Password:

Symdeko

This page shows the latest Symdeko news and features for those working in and with pharma, biotech and healthcare.

Vertex rises on data for cystic fibrosis triple therapy

Vertex rises on data for cystic fibrosis triple therapy

The interim results come from two studies of its two-drug therapy Symdeko (ivacaftor/tezacaftor) – which has just been approved as Symkevi in Europe – with experimental candidate VX-659, and reveal ... that the regimen achieved a significant

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics